slider4
slider3
slider2
slider1
Search:

Dr. John Paul Micha - Ovarian Cancer Vaccine

Ovarian Cancer Vaccine

Graph



We Have Published Our 100th Publication!!!



Peer review journals only publish new, important, innovative articles. This is how researchers communicate and in turn how new cures are found.

We are dedicated to improving the cure rates of women with gynecologic cancer through innovative clinical research.  Gynecologic cancer is any cancer that is part of a woman’s reproductive organs and includes:
    • Ovarian
    • Endometrial
    • Fallopian Tube
    • Cervical
    • Peritoneal
    • Uterine
    • Vaginal
    • Vulvar
Ovarian Cancer Vaccine Update

We had an excellent meeting with Dr. Robert Dillman and CSR biotech personnel recently.  The first phase of this project should launch soon.  This first phase will involve collecting ovarian cancer specimen from six patients, and making individual vaccines for each patient.  We need to do this to prove that the vaccine production process is perfected.  We will then be able to move on to the actual vaccine trial, involving approximately ninety six patients.  Hopefully the trial will start in January/February of 2015.  If you would like to make a donation to support this “first in the world” trial, this can be done either in person at our office located at 351 Hospital Road Suite 506 Newport Beach, CA., 92663 or online at
https://nancycancer.com/donations/

 

Metformin Ovarian Cancer Trial

 

NYWCRF is actively working with the University of North Carolina (UNC) and Gynecologic Oncology Associates of Newport Beach to design a first line trial adding metformin to gold standard taxol/carboplatin chemotherapy treatment.  Several retrospective trials have shown that metformin may be useful in treating cancer and possibly preventing cancer from developing.  UNC has extensive animal data suggesting that this new combination might improve ovarian cancer cure rates.  This will be a first in the world trial in humans.  We expect the treatment to be well tolerated.  Since metformin is off patent, no pharmaceutical company will fund the trial.  NYWCRF will therefore fund this important trial itself.  If you would like to help support this trial you can make a tax deductible donation on our website at,
https://nancycancer.com/donations/

 

Swing For the Cure – August 26th, 2014

The World's Fair

Swing for The Cure

 

In Memory of
Jacqualine Quijada

Jacqualine Quijada

Jacqualine was 26 years old when she was diagnosed with stage IIB Cervical cancer. Of course the initial shock of the word cancer brought her to her knees in tears, but she picked herself up and stood strong in her faith. She gathered courage and marched forward in her fight, never having a pity party, whoa is me, or complaint. Through all the surgeries, the chemo, the radiation, she fought the fight as hard as she could. She eventually lost the battle, but the fight continues as we join The Nancy Yeary Women’s Cancer Research Foundation. Will you help us by donating in Jacqualine’s memory as we continue to search for the cure?

 

For wire transfers, please contact Janet Rae at 949-642-5165 or Janet.Rae@gynoncology.com

 

 

The Nancy Yeary Women’s Cancer Research Foundation is a proud sponsor of Globeathon.

The Global Video: The Global Video

The Universal Video: The Universal Video